Steven Tredget - Oakley Capital Partner
| OCI Stock | 489.50 3.50 0.72% |
Executive
Steven Tredget is Partner of Oakley Capital Investments
| Address | Rosebank Centre, Pembroke, Bermuda, HM 08 |
| Phone | 441 542 6742 |
| Web | https://www.oakleycapitalinvestments.com |
Oakley Capital Management Efficiency
The company has return on total asset (ROA) of 0.0433 % which means that it generated a profit of $0.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0728 %, meaning that it generated $0.0728 on every $100 dollars invested by stockholders. Oakley Capital's management efficiency ratios could be used to measure how well Oakley Capital manages its routine affairs as well as how well it operates its assets and liabilities. At present, Oakley Capital's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.5 M, whereas Total Current Assets are forecasted to decline to about 113.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Sofia Nilsson | Coor Service Management | N/A | |
| Alexandra HughesWilson | Mereo BioPharma Group | 53 | |
| Daniel Evestedt | Surgical Science Sweden | 47 | |
| Suba Krishnan | Mereo BioPharma Group | 59 | |
| Jeffrey Berkley | Surgical Science Sweden | 55 | |
| Christine CPA | Mereo BioPharma Group | 43 | |
| Matthew Hall | Oncimmune Holdings plc | N/A | |
| John Lewicki | Mereo BioPharma Group | 72 | |
| BA FCA | Oncimmune Holdings plc | 56 | |
| Erik Strmpel | Coor Service Management | 54 | |
| Cla Rosenfeld | Oncimmune Holdings plc | N/A | |
| Cameron Barnard | Oncimmune Holdings plc | N/A | |
| Martin Jansson | Surgical Science Sweden | 53 | |
| Bo Kara | Mereo BioPharma Group | N/A | |
| Peter Viinapuu | Coor Service Management | 60 | |
| Maarten Brusse | Oncimmune Holdings plc | N/A | |
| Tom Englund | Surgical Science Sweden | 48 | |
| BSc FRCP | Oncimmune Holdings plc | N/A | |
| Katarina Andersson | Coor Service Management | N/A | |
| Christer Olsson | Coor Service Management | N/A | |
| Fiona Bor | Mereo BioPharma Group | N/A | |
Management Performance
| Return On Equity | 0.0728 | ||||
| Return On Asset | 0.0433 |
Oakley Capital Inves Leadership Team
Elected by the shareholders, the Oakley Capital's board of directors comprises two types of representatives: Oakley Capital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Oakley. The board's role is to monitor Oakley Capital's management team and ensure that shareholders' interests are well served. Oakley Capital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Oakley Capital's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sascha Guenther, Partner | ||
| Sascha Gnther, Partner | ||
| Lovis Andrian, Investment Director | ||
| Steven Tredget, Partner | ||
| Jonathan Clapham, Investment Mang | ||
| James Isola, Head Communications | ||
| Peter Dubens, Managing CoFounder | ||
| Sam FentonWhittet, Partner | ||
| David Till, Partner CoFounder | ||
| Valero Domingo, Partner | ||
| Aga Siemiginowska, Head Sustainability | ||
| Mike Mutsaers, Investment Mang |
Oakley Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Oakley Capital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0728 | ||||
| Return On Asset | 0.0433 | ||||
| Profit Margin | 0.89 % | ||||
| Operating Margin | 0.93 % | ||||
| Current Valuation | 850.25 M | ||||
| Shares Outstanding | 176.42 M | ||||
| Shares Owned By Insiders | 20.80 % | ||||
| Shares Owned By Institutions | 54.15 % | ||||
| Price To Book | 0.69 X | ||||
| Price To Sales | 9.38 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Oakley Stock
Oakley Capital financial ratios help investors to determine whether Oakley Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oakley with respect to the benefits of owning Oakley Capital security.